Trial
NCT00965419
A Study of Pediatric Participants With Attention Deficit/Hyperactivity Disorder
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Eli Lilly and Company
Collaborators
—
Condition
Attention Deficit Hyperactivity Disorder
Intervention
Edivoxetine
Why stopped
Terminated due to low 5 year completer number and not meeting primary objective.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-10-08